Dual Acting Neuraminidase Inhibitors Open New Opportunities to Disrupt the Lethal Synergism between Streptococcus pneumoniae and Influenza Virus
Elisabeth Walther(Jena University Hospital), Michaela Schmidtke(Jena University Hospital), W. Pfister, Zhongli Xu(Inflarx (Germany)), Hans Peter Saluz(Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI)), Judith M. Rollinger(University of Vienna), Ulrike Grienke(Universität Innsbruck), Andreas Sauerbrei(Jena University Hospital), Martina Richter(Jena University Hospital), Johannes Kirchmair(Niigata University of Pharmacy and Medical and Life Sciences), Andi Krumbholz(Christian-Albrechts-Universität zu Kiel)
Cited by 43
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Discovery and resupply of pharmacologically active plant-derived natural products: A review
|Biotechnology Advances|2015|2.9k
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
|Biochemical Pharmacology|2014|593
Predicting drug metabolism: experiment and/or computation?
|Nature Reviews Drug Discovery|2015|500
Energy/Temperature Diagram and Compression Behavior of the Polymorphs of d-Mannitol
|Journal of Pharmaceutical Sciences|2000|363